Researcher
Patrick Neven
- Disciplines:Gynaecology and obstetrics, Nursing, Endocrinology and metabolic diseases
Affiliations
- Gynaecological Oncology (Division)
Member
From1 Jan 2012 → Today
Projects
1 - 10 of 13
- Early folliculogenesis and ovarian aging in women with genetic predisposition to (breast)cancerFrom15 Jul 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Development, Validation, and Valorization of a Patient Preference Platform to Inform Healthcare Decision-MakingFrom1 Mar 2023 → TodayFunding: IOF - technology validation in lab
- Effectiveness of an eHealth self-management support program for persistent pain after breast cancer treatmentFrom1 Oct 2022 → TodayFunding: FWO Applied Biomedical Research (TBM)
- breastcancer and sexualityFrom25 Sep 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Clinical, pathological and molecular characterization of invasive lobular carcinoma (ILC)From12 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Epidemiological study of relapse in breast, ovarian and cervical cancers.From1 Oct 2018 → 30 Sep 2021Funding: Nonprofit institution or equivalents
- Towards a better selection of systemic treatment for patients with ER-positive HER2-negative breast cancer: the use of prognostic and predictive markers in early and metastatic settingFrom1 May 2017 → 14 Oct 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Role of combined chemo- and immunotherapy in early breast cancerFrom1 Oct 2016 → 30 Sep 2020Funding: Nonprofit institution or equivalents
- Key biological processes involved in breast cancer invasion and metastases leading to residual disease after local therapy of breast tumors.From1 Jul 2014 → 30 Jun 2018Funding: Private funding of national origin - undefined
- Assessment of market access policies and instruments for oncology drugs.From1 Jan 2014 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 571
- Serum methylmalonic acid concentrations at breast cancer diagnosis significantly correlate with clinical frailty(2024)
Authors: Sigrid Hatse, Cindy Kenis, Anke Vandekeere, Yentl Lambrechts, François Richard, Patrick Neven, Ines Nevelsteen, Christine Desmedt, Sarah-Maria Fendt, Hans Wildiers
- Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials(2024)
Authors: Patrick Neven
- Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes.(2024)
Authors: Patrick Neven
Pages: 987 - 993 - Reporting on invasive lobular breast cancer in clinical trials: a systematic review.(2024)
Authors: Karen Van Baelen, Josephine Van Cauwenberge, Beppe Floris, Patrick Neven, Hans Wildiers, Christine Desmedt
Pages: 23 - Aging-accumulated methylmalonic acid serum levels at breast cancer diagnosis are not associated with distant metastases(2024)
Authors: Sigrid Hatse, Cindy Kenis, Anke Vandekeere, François Richard, Patrick Neven, Sarah-Maria Fendt, Hans Wildiers
- Treatment response, tumor infiltrating lymphocytes and clinical outcomes in inflammatory breast cancer treated with neoadjuvant systemic therapy.(2023)
Authors: Maxim De Schepper, Ha Linh Nguyen, François Richard, Sophia Leduc, Hans Wildiers, Ines Nevelsteen, Patrick Neven, Beppe Floris, Christine Desmedt
Pages: 186 - 199 - AMEERA-4: a randomized, preoperative window-of-opportunity study of amcenestrant versus letrozole in early breast cancer(2023)
Authors: Patrick Neven
- Pooled ctDNA analysis of MONALEESA phase III advanced breast cancer trials(2023)
Authors: Patrick Neven
Pages: 1003 - 1014 - The effect of myofascial and physical therapy on trunk, shoulder, and elbow movement patterns in women with pain and myofascial dysfunctions after breast cancer surgery: Secondary analyses of a randomized controlled trial(2023)
Authors: An De Groef, Michiel Hagen, Patrick Neven, Inge Geraerts, Anne Asnong, Tessa De Vrieze, Nieke Vets, Nele Devoogdt
Pages: 1382 - 1391 - Navigating next-generation HR+ /HER2− metastatic breast cancer therapies: a critical commentary on abemaciclib vs. tucidinostat after palbociclib progression(2023)
Authors: Patrick Neven, Sileny Han, Yannick Van Herck, Hans Wildiers